// App-Quantinova.ai

2958 : Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Researchers

Presenter

  • Suzanne O Arulogun

Principal Investigators

  • Harshita Goradia

  • Aaron Cooney

  • Tobias Menne

  • Dipti Talaulikar

  • Aideen Therese O'Neill

  • Josephine M.I Vos

  • Guy Pratt

  • Deborah Turner

  • Kirsty Marshall

  • Kate Manos

  • Claire Anderson

  • Maria Gavriatopoulou

  • Charalampia Kyriakou

  • Monique C. Minnema

  • Dima El-Sharkawi

  • Marie Jos Kersten

  • RayMun Koo

  • Helen McCarthy

  • Mark Bishton

  • George Follows

  • Ashutosh D. Wechalekar

  • Shirley D'Sa

Medical Centers

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • Royal Bournemouth Hospital, Bournemouth, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Medical School, Australian National University, Canberra, ACT, Australia

  • Department of Medical Oncology, The Canberra Hospital, Garran, Australia

  • Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, Netherlands

  • Centre for Clinical Haematology, University Hospital Birmingham, Birmingham, United Kingdom

  • Torbay Hospital, Torquay, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Department of Clinical Haematology, Austin Hospital, Melbourne, Australia

  • Barnet and Chase Farm Hospitals NHS Trust, Gastroenterology, London, United Kingdom

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

  • London North West University Healthcare NHS Trust and University College London Hospital, London, United Kingdom

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Hematology,Amsterdam UMC, University of Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Cancer Center Amsterdam,Amsterdam,Netherlands

  • Canberra Health Services, Canberra, Australia

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth, United Kingdom

  • University College London and the Royal Free London NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

  • Australia

  • Netherlands

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Bendamustine

  • Rituximab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved